FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372515005: Salmeterol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197808015 Salmeterol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211049017 Salmeterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
53721000195113 salmeterolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
839271000172112 salmétérol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68651000195111 Salmeterol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salmeterol (substance) Is a Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) true Inferred relationship Some
Salmeterol (substance) Is a Bronchodilator agents false Inferred relationship Some
Salmeterol (substance) Is a Respiratory sympathomimetic agent false Inferred relationship Some
Salmeterol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta adrenergic receptor agonist (disposition) false Inferred relationship Some
Salmeterol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta-2 adrenergic receptor agonist true Inferred relationship Some
Salmeterol (substance) Is a Substance with phenol structure true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Salmeterol xinafoate Is a False Salmeterol (substance) Inferred relationship Some
Product containing salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Some 1
Salmeterol adverse reaction Causative agent (attribute) True Salmeterol (substance) Inferred relationship Some 1
Allergy to salmeterol Causative agent (attribute) False Salmeterol (substance) Inferred relationship Some
Salmeterol 25mcg inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol 50micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol 50micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol 50micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Product containing fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Some 1
Fluticasone propionate + salmeterol xinafoate 250mcg/50mcg powder for oral inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Fluticasone propionate + salmeterol xinafoate 500mcg/50mcg powder for oral inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Allergy to salmeterol Causative agent (attribute) True Salmeterol (substance) Inferred relationship Some 1
Salmeterol xinafoate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/250micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/125micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Some
Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1
Salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Salmeterol (substance) Inferred relationship Some 2
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1
Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1
Product containing salmeterol in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Some 1
Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Some 1
Product containing only fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Some 1
Product containing only salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Some 1
Fluticasone and salmeterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Some 1
Salmeterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Some 1
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Salmeterol (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start